Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease

Published:2024-02 Issue: Volume:120 Page:99-106
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Martínez-Domínguez Samuel J.^ORCID,García-Mateo Sandra^ORCID,Gargallo-Puyuelo Carla J.,Gallego Llera Beatriz,Refaie Engy,Callau Pilar,Mendi Carolina,Baptista Pedro M.,Hernández Ainsa María,Arroyo-Villarino María Teresa,López de la Cruz Julia,Martínez-García Javier^ORCID,Alfambra Erika,Simón Marco Miguel Ángel,Ampuero Javier,Gomollón Fernando

Publisher

Elsevier BV

Subject

Internal Medicine

Reference39 articles.

1. The four epidemiological stages in the global evolution of inflammatory bowel disease;Kaplan;Nat Rev Gastroenterol Hepatol,2021

2. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: large-scale epidemiological study;Chaparro;J Clin Med,2021

3. Nutrition in patients with inflammatory bowel diseases: a narrative review;Roncoroni;Nutrients,2022

4. ESPEN guideline: clinical nutrition in inflammatory bowel disease;Bischoff;Nutr Hosp,2022

5. A multi-society Delphi consensus statement on new fatty liver disease nomenclature;Rinella;Hepatol Baltim Md,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When metabolic comorbidities and risk of malnutrition coexist: The new era of inflammatory bowel disease;The American Journal of the Medical Sciences;2024-08

2. Heavy arch: from inflammatory bowel diseases to metabolic disorders;Gut;2024-05-22